EE5 Stock Overview
Engages in the research and development, planning, manufacture, and sale of laser systems in Italy, rest of Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
EL.En. S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €11.64 |
| 52 Week High | €12.07 |
| 52 Week Low | €8.20 |
| Beta | 1.59 |
| 11 Month Change | 8.38% |
| 3 Month Change | 24.03% |
| 1 Year Change | 22.20% |
| 33 Year Change | -25.00% |
| 5 Year Change | 49.14% |
| Change since IPO | 60.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| EE5 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 17.1% | 3.8% | -1.2% |
| 1Y | 22.2% | -2.9% | 9.0% |
Return vs Industry: EE5 exceeded the German Medical Equipment industry which returned 4.6% over the past year.
Return vs Market: EE5 exceeded the German Market which returned 13.5% over the past year.
Price Volatility
| EE5 volatility | |
|---|---|
| EE5 Average Weekly Movement | 6.4% |
| Medical Equipment Industry Average Movement | 4.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: EE5 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: EE5's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 2,030 | n/a | elengroup.com |
EL.En. S.p.A. engages in the research and development, planning, manufacture, and sale of laser systems in Italy, rest of Europe, and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; EchoLaser, an integrated laser-ultrasound system that allows diagnosis and treatment of benign and malignant lesions; hair removal and non-invasive body contouring products; and laser sources and systems for cutting, welding, marking, and engraving on countless materials.
EL.En. S.p.A. Fundamentals Summary
| EE5 fundamental statistics | |
|---|---|
| Market cap | €912.78m |
| Earnings (TTM) | €49.76m |
| Revenue (TTM) | €659.63m |
18.3x
P/E Ratio1.4x
P/S RatioIs EE5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EE5 income statement (TTM) | |
|---|---|
| Revenue | €659.63m |
| Cost of Revenue | €412.27m |
| Gross Profit | €247.35m |
| Other Expenses | €197.59m |
| Earnings | €49.76m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 14, 2024
| Earnings per share (EPS) | 0.62 |
| Gross Margin | 37.50% |
| Net Profit Margin | 7.54% |
| Debt/Equity Ratio | 19.1% |
How did EE5 perform over the long term?
See historical performance and comparison